ALG-055009
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ALG-055009, covering 2025-02-17 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations [Phase 1]